Literature DB >> 25010267

The neutralizing capacity of antibodies elicited by parainfluenza virus infection of African Green Monkeys is dependent on complement.

Anne E Mayer1, John B Johnson1, Griffith D Parks2.   

Abstract

The African Green Monkey (AGM) model was used to analyze the role of complement in neutralization of parainfluenza virus. Parainfluenza virus 5 (PIV5) and human parainfluenza virus type 2 were effectively neutralized in vitro by naïve AGM sera, but neutralizing capacity was lost by heat-inactivation. The mechanism of neutralization involved formation of massive aggregates, with no evidence of virion lysis. Following inoculation of the respiratory tract with a PIV5 vector expressing HIV gp160, AGM produced high levels of serum and tracheal antibodies against gp120 and the viral F and HN proteins. However, in the absence of complement these anti-PIV5 antibodies had very poor neutralizing capacity. Virions showed extensive deposition of IgG and C1q with post- but not pre-immune sera. These results highlight the importance of complement in the initial antibody response to parainfluenza viruses, with implications for understanding infant immune responses and design of vaccine strategies for these pediatric pathogens.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complement; Immune; Parainfluenza; Vaccine

Mesh:

Substances:

Year:  2014        PMID: 25010267      PMCID: PMC4101032          DOI: 10.1016/j.virol.2014.05.004

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  45 in total

1.  Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype.

Authors:  Jing Qi Feng; Krystyna Mozdzanowska; Walter Gerhard
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

Review 2.  Complement: a unique innate immune sensor for danger signals.

Authors:  Philippe Gasque
Journal:  Mol Immunol       Date:  2004-11       Impact factor: 4.407

Review 3.  The complement system in regulation of adaptive immunity.

Authors:  Michael C Carroll
Journal:  Nat Immunol       Date:  2004-10       Impact factor: 25.606

4.  Biochemical abnormalities of the third component of complement in neonates.

Authors:  T L Zach; M K Hostetter
Journal:  Pediatr Res       Date:  1989-08       Impact factor: 3.756

5.  Antibody avidity determination by ELISA using thiocyanate elution.

Authors:  G R Pullen; M G Fitzgerald; C S Hosking
Journal:  J Immunol Methods       Date:  1986-01-22       Impact factor: 2.303

6.  Activation of the alternative complement pathway by enveloped viruses containing limited amounts of sialic acid.

Authors:  J J McSharry; R J Pickering; L A Caliguiri
Journal:  Virology       Date:  1981-10-30       Impact factor: 3.616

7.  Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.

Authors:  D P Beebe; N R Cooper
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

8.  Activation of the alternative complement pathway by mumps infected cells: relationship to viral neuraminidase activity.

Authors:  R L Hirsch; J S Wolinsky; J A Winkelstein
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

9.  Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.

Authors:  M K Pangburn; R D Schreiber; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1981-09-01       Impact factor: 14.307

Review 10.  The relevance of complement to virus biology.

Authors:  Clare E Blue; O Brad Spiller; David J Blackbourn
Journal:  Virology       Date:  2004-02-20       Impact factor: 3.616

View more
  2 in total

Review 1.  A game of numbers: the stoichiometry of antibody-mediated neutralization of flavivirus infection.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Prog Mol Biol Transl Sci       Date:  2014-12-01       Impact factor: 3.622

Review 2.  Respiratory nanoparticle-based vaccines and challenges associated with animal models and translation.

Authors:  Gourapura J Renukaradhya; Balaji Narasimhan; Surya K Mallapragada
Journal:  J Control Release       Date:  2015-09-26       Impact factor: 9.776

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.